SPY
760.02
−0.52%
QQQ
702.37
−0.30%
BTC/USD
81,862.19
+0.69%
DIA
522.49
−1.02%
GLD
368.99
−0.00%
TLT
81.75
+0.01%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Alcon Inc
ALC
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$70.28
-0.35
-0.5%
Last update: Oct 23, 9:34 AM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Dividends
Compare
Options
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
M&A:
Neurotech Pharmaceuticals, Inc was acquired by Alcon (ALC) on Tuesday, October 20, 2026 for $550M
Alcon Financials
Alcon (ALC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Alcon Raises FY2026 Adj EPS Guidance from $3.38-$3.47 to $3.44-$3.53 vs $3.41 Est; Widens FY2026 Sales Guidance of $10.835B-$11.041B vs $11.087B Est
Alcon (NYSE:ALC) raises FY2026 Adj EPS guidance from $3.38-$3.47 to $3.44-$3.53 vs $3.41 analyst estimate. Widens FY2026 sales outlook from $10.835 billion-$11.041 billion to $10.835 billion-$11.041 billion vs $11.087
Benzinga Newsdesk
PRO
Alcon Q2 Adj. EPS $0.84 Beats $0.75 Estimate, Sales $2.782B Beat $2.769B Estimate
Alcon (NYSE:ALC) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.75 by 12 percent. This is a 10.53 percent increase over earnings of $0.76 per share from the same period
Benzinga Newsdesk
S&P 500 Surges To Record Close Following Jobs Data: Investor Sentiment Improves, Fear Index Remains in ‘Greed’ Zone
U.S. stocks closed higher, with Nasdaq up 300 points. S&P 500 and Nasdaq rose for the second consecutive week. Fear & Greed index in Greed zone.
Avi Kapoor
Aecom, Alcon And 3 Stocks To Watch Heading Into Monday
U.S. stock futures mixed, Aecom and Hawaiian Electric report earnings, Alcon expected to release earnings, Check Cap announces reverse split, Monday.Com expected to post earnings.
Avi Kapoor
PRO
Alcon Raises FY2026 Adj EPS Guidance from $3.35-$3.44 to $3.38-$3.47 vs $3.38 Est; Affirms FY2026 Sales Guidance of $10.835B-$11.041B vs $11.117B Est
Alcon (NYSE:ALC) raises FY2026 Adj EPS guidance from $3.35-$3.44 to $3.38-$3.47 vs $3.38 analyst estimate. Affirms FY2026 sales outlook from $10.835 billion-$11.041 billion to $10.835 billion-$11.041 billion vs $11.117
Benzinga Newsdesk
PRO
Alcon Q1 Adj. EPS $0.85 Beats $0.81 Estimate, Sales $2.685B Miss $2.712B Estimate
Alcon (NYSE:ALC) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.81 by 4.94 percent. This is a 16.44 percent increase over earnings of $0.73 per share from the same period
Benzinga Newsdesk